Vestmark Advisory Solutions’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-53,244
Closed -$890K 883
2023
Q1
$890K Sell
53,244
-5,538
-9% -$89.2K 0.04% 464
2022
Q4
$907K Sell
58,782
-10,273
-15% -$159K 0.04% 442
2022
Q3
$1.03M Buy
69,055
+1,239
+2% +$20.5K 0.06% 371
2022
Q2
$1.11M Buy
67,816
+1,676
+3% +$28.7K 0.06% 341
2022
Q1
$1.33M Buy
66,140
+4,687
+8% +$97.3K 0.08% 306
2021
Q4
$1.56M Buy
61,453
+13,640
+29% +$352K 0.09% 280
2021
Q3
$1.29M Sell
47,813
-4,733
-9% -$136K 0.09% 290
2021
Q2
$1.52M Buy
52,546
+401
+0.8% +$11.1K 0.11% 240
2021
Q1
$1.37M Buy
+52,145
New +$1.48M 0.12% 225

Other funds holding BMEZ

Vestmark Advisory Solutions's BMEZ Position: Q2 2023 in Review

Vestmark Advisory Solutions sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2023, closing a stake of 53,244 shares — an estimated $890K sold.

Vestmark Advisory Solutions first reported a position in BMEZ in Q1 2021 and held it in 9 quarters. The position peaked at $1.56M in Q4 2021. 91 funds tracked by Wall St. Rank hold BMEZ as of Q2 2023.

  • Vestmark Advisory Solutions reported no remaining BlackRock Health Sciences Trust II position as of Q2 2023 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 53,244 BlackRock Health Sciences Trust II shares in Q2 2023, an estimated $890K.
  • Vestmark Advisory Solutions first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and held it in 9 quarters.
  • Vestmark Advisory Solutions's BlackRock Health Sciences Trust II position peaked at $1.56M in Q4 2021.
  • 91 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2023.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2023, filed 7 Aug 2023.